Skip to content

SCREENER CHART SD50 CALENDAR NEWS

...

Crescent Biopharma, Inc. (CBIO) Stock · SELL · CRISIS | LOPJLB

Crescent Biopharma, Inc. (CBIO)

Healthcare · Biotechnology · NASDAQ · US

$14.91+5.59%Close

SELLCRISIS · day 18

CBIO▼ SELL

$14.91+5.59%

Overview FinancialsFin EarningsEarn Analyst & RatingsAnalyst News Holders & ETFsHold Options

Key stats

Short interest · FINRA settlement 2026-09-30

Market cap: $411M
Beta: 1.26
P/E (TTM): -1.79

Short % float: 22.40%
Days to cover: 6.8
SI change: +40.2%

1W: +4.12%
1M: -23.38%

vs SPY 1W: +2.56%
vs SPY 1M: -25.15%

Industry peers

FMP comparable companies · ranked by market cap

OABIBUYOmniAb, Inc.$706MBEARQ -11$4.87+2.79%

Prediction markets

Kalshi · Polymarket · … linked

Full prediction markets →

Loading markets…

Company

Crescent Biopharma, Inc. is a biotechnology firm dedicated to the research and development of novel cancer therapies. Its investigational portfolio notably includes CR-001, a proprietary bispecific antibody engineered to simultaneously target PD-1 and VEGF pathways for the…

Employees: 44
Headquarters: US
Founded: 2014
Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Shares out: 27.6M
Float: 77.3%

crescentbiopharma.com ↗

Key executives

Joshua T. Brumm — Chief Executive Officer & Director

Jonathan McNeill — President & Chief Operating Officer

Ellie Im — Chief Medical Officer

SEC filings

EDGAR · CIK 12536890 · CBIO

All filings
10-K
10-Q
8-K
Form 4

Analyst consensus

Buy

Bullish1071.4%

Neutral428.6%

Bearish00.0%

L $36.00Avg $36.00H $36.00

Target$36.00+141.45%

Last$14.91

Company news

globenewswire.com · 4d ago

Crescent Biopharma Announces Grants of Inducement Awards

globenewswire.com · 5d ago

Crescent Biopharma Announces FDA Clearance of IND Application for CR-002, a PD-L1-targeted Topoisomerase Inhibitor ADC, for the Treatment of Solid Tumors

globenewswire.com · 15d ago

Crescent Biopharma Announces Grants of Inducement Awards

defenseworld.net · 19d ago

Insider Selling: Crescent Biopharma (NASDAQ:CBIO) Insider Sells $11,098.00 in Stock

defenseworld.net · 19d ago

Insider Selling: Crescent Biopharma (NASDAQ:CBIO) CEO Sells $28,819.00 in Stock

defenseworld.net · 19d ago

Insider Selling: Crescent Biopharma (NASDAQ:CBIO) Insider Sells $11,151.70 in Stock

defenseworld.net · 19d ago

Insider Selling: Crescent Biopharma (NASDAQ:CBIO) CFO Sells $10,167.20 in Stock

defenseworld.net · 19d ago

Insider Selling: Crescent Biopharma (NASDAQ:CBIO) Insider Sells $11,778.20 in Stock

defenseworld.net · 19d ago

Insider Selling: Crescent Biopharma (NASDAQ:CBIO) COO Sells $13,084.90 in Stock

defenseworld.net · 20d ago

Jonathan Mcneill Sells 3,839 Shares of Crescent Biopharma (NASDAQ:CBIO) Stock

defenseworld.net · 20d ago

Joshua Brumm Sells 7,837 Shares of Crescent Biopharma (NASDAQ:CBIO) Stock

defenseworld.net · 23d ago

Head-To-Head Comparison: Crescent Biopharma (NASDAQ:CBIO) vs. Vir Biotechnology (NASDAQ:VIR)

seekingalpha.com · 25d ago

Crescent Biopharma, Inc. (CBIO) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

globenewswire.com · 31d ago

Crescent Biopharma Announces Grants of Inducement Awards

globenewswire.com · 37d ago

Crescent Biopharma to Present at September Investor Conferences

globenewswire.com · 68d ago

Crescent Biopharma Announces Grants of Inducement Awards

globenewswire.com · 72d ago

Crescent Biopharma Reports Second Quarter 2026 Financial Results and Recent Business Highlights

globenewswire.com · 79d ago

Crescent Biopharma Announces Grants of Inducement Awards

globenewswire.com · 86d ago

Crescent Biopharma Announces Closing of Public Offering of Ordinary Shares and Pre-Funded Warrants, Including Full Exercise of Underwriters' Option to Purchase Additional Shares

globenewswire.com · 87d ago

Crescent Biopharma Announces Pricing of Public Offering of Ordinary Shares and Pre-Funded Warrants

Market news & ticker search · RSS for CBIO

LOPJLB

Independent quant research on U.S. equities & ETFs. Not personalized advice.

Product

Screener Chart Compare SD50 Thesis News Calendar

Desk

Market Heatmap Market Hours FOMC Desk Treasury Rates Congress Trades Prediction Markets

Research

How It Works Methodology Track Record Editorial Blog Changelog

Ledgers

Bull Spreads Cash-Secured Puts Covered Calls Long Puts Long Calls

Screeners

CEF Screener REIT Screener BDC Screener Preferred Screener Dividend Screener ETF Screener Crypto Screener S&P 500 Screener

Company

Pricing About Contact

Agents

GitHub·Research Chat·MCPENT·Developers

© 2026 LOPJLB Research. All rights reserved.

@lopjlb contact@lopjlb.com

RANGE

LOPJLB.COM

OHLC🔒EMALEVELS🔒STOP🔒FLIP🔒52WSIGNALS🔒BUY🔒SELL🔒EXH🔒EXH ZONE🔒BEST